# ExpressCells, Inc. — Form D/A

ExpressCells, Inc. of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2019-09-26. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-09-26
- Form: D/A
- Accession: 0001780502-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 17
- Date of first sale: 2019-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342555

## Issuer

- Name: ExpressCells, Inc.
- CIK: 0001780502
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3675 MARKET ST., SUITE 200, PHILADELPHIA, PA, 19104
- Phone: 484-802-7419

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Tom Anderson | Director | Chicago, IL |
| Wendy DiCicco | Director | Boston, MA |
| Matthew Handel | Director | Philadelphia, PA |
| Matthew Handel | Executive Officer | Philadelphia, PA |
| Sajad Bilgrami | Director | Philadelphia, PA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-04-09](https://search.stillhousedata.com/formd/0001780502-21-000001) | D | $650K | $591K |
| [2019-06-24](https://search.stillhousedata.com/formd/0001780502-19-000001) | D | $1.0M | $800K |

## More

- [CIK 1780502 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1780502&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001780502-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.